The new FlowCam® LO improves particle characterization in drug development

Yokogawa Fluid Imaging Technologies announces the release of the FlowCam® LO, the first and only light obscuration (LO) instrument with imaging capabilities. This easy-to-use instrument combines Flow Imaging Microscopy (FIM) with LO to deliver a powerful, all-in-one solution that meets compliance standards while allowing verification with high-resolution images.

Regulatory agencies have long made clear that orthogonal particle characterization methods are necessary, especially for protein-based biologics since size and counts from LO alone are not adequate to ensure product quality and stability. The FlowCam LO fulfills this need, while providing a single USP-compliant software package for acquisition and analysis of multiple data sets and reporting via VisualSpreadsheet Software.

Over the past ten years FIM has become one of the essential tools used in the biopharmaceutical industry due to its ability to accurately identify and classify subvisible particles in liquid media. With automated high-resolution imaging, particle identification and morphology are confidently and readily determined and displayed in real-time, speeding up formulation development.

By contrast, QC departments have long relied on the legacy method of light obscuration to provide particle size and count data for product release, as most pharmacopeias and related regulations have historically been written around this technique. With the FlowCam LO, a single solution bridges the gap between product formulation and QA/QC requirements.

Customers are looking for ways to speed drug development while also adhering to increased regulatory requirements. The FlowCam LO brings together two critical particle characterization techniques in a single platform to meet this demand. We are very excited to be doing our part to provide this much needed solution to the market.

Ross Bryant, President and CEO

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Yokogawa Fluid Imaging Technologies, Inc.. (2021, September 29). The new FlowCam® LO improves particle characterization in drug development. AZoLifeSciences. Retrieved on October 26, 2021 from https://www.azolifesciences.com/news/20210929/The-new-FlowCamc2ae-LO-improves-particle-characterization-in-drug-development.aspx.

  • MLA

    Yokogawa Fluid Imaging Technologies, Inc.. "The new FlowCam® LO improves particle characterization in drug development". AZoLifeSciences. 26 October 2021. <https://www.azolifesciences.com/news/20210929/The-new-FlowCamc2ae-LO-improves-particle-characterization-in-drug-development.aspx>.

  • Chicago

    Yokogawa Fluid Imaging Technologies, Inc.. "The new FlowCam® LO improves particle characterization in drug development". AZoLifeSciences. https://www.azolifesciences.com/news/20210929/The-new-FlowCamc2ae-LO-improves-particle-characterization-in-drug-development.aspx. (accessed October 26, 2021).

  • Harvard

    Yokogawa Fluid Imaging Technologies, Inc.. 2021. The new FlowCam® LO improves particle characterization in drug development. AZoLifeSciences, viewed 26 October 2021, https://www.azolifesciences.com/news/20210929/The-new-FlowCamc2ae-LO-improves-particle-characterization-in-drug-development.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.